I'll have a crack... Total annual global addressable market for...

I'll have a crack...

Total annual global addressable market for HIV and Covid - $45B

Assumptions (big):

1. BIT225 is significantly more affordable than current treatments, therefore total addressable market is say $22B
2. Biotron - BP partnership has 50% of global market say $11B
3. Biotron negotiates 10% as their share - say $1B
4. PE ratio of 10
5. BIT valuation $10B or SP of $10.00
6. Assume release of successful trial results with no partnership announced is 10% of ultimate valuation - so $1.00. Could say spike to $2 after announcement.
7. On release of BP partnership but with stage 3 trial outstanding say $3 perhaps peaking at $5

Obviously valuation is highly sensitive to the assumptions... interested in others views and happy for all of the above to be challenged
GLTAH